News for Voyager Therapeutics, Inc. (VYGR)

Published at

Mar 17, 2025 10:00 PM

by gurufocus.com

positive

positive

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc. - VYGR

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Voyager Therap

VYGR.MX VYGR

Read more →
Published at

Mar 12, 2025 6:03 AM

by gurufocus.com

positive

positive

Q4 2024 Voyager Therapeutics Inc Earnings Call Transcript

Mar 11, 2025 / 08:30PM GMTOperator Good afternoon and welcome to Voyager Therapeutics fourth-quarter and year-end 2024 financial results conference call. (Opera

VYGR.MX VYGR

Read more →
Published at

Mar 12, 2025 12:35 AM

by seekingalpha.com

positive

positive

Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call Transcript

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ETCompany ParticipantsTrista Morrison - Chief Corporate...

VYGR.MX VYGR

Read more →
Published at

Mar 11, 2025 10:10 PM

by zacks.com

negative

negative

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -68.57% and 68.81%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

VYGR

Read more →
Published at

Mar 11, 2025 9:16 PM

by manilatimes.net

mixed

mixed

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

**media[563711]**

VYGR.MX VYGR NBIX AZN 0K6R.L

Read more →
Published at

Mar 10, 2025 10:35 PM

by seekingalpha.com

neutral

neutral

Voyager Therapeutics Q4 2024 Earnings Preview (NASDAQ:VYGR)

Voyager Therapeutics (VYGR) Q4 earnings release set for March 11th. Analysts forecast EPS of -$0.35 and $16.58M revenue.

VYGR

Read more →
Published at

Mar 4, 2025 1:00 PM

by gurufocus.com

mixed

mixed

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

LEXINGTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. ( VYGR), a biotechnology company dedicated to advancing neurogenetic medicines

VYGR.MX VYGR NBIX 0K6R.L

Read more →
Published at

Mar 3, 2025 9:00 PM

by gurufocus.com

positive

positive

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc. - VYGR

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Voyager Therapeu

VYGR.MX VYGR

Read more →
Published at

Mar 3, 2025 1:00 PM

by gurufocus.com

mixed

mixed

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer's Disease

- Topline SAD data from healthy volunteers demonstrate safety, tolerability, and dose-proportional pharmacokinetics, supporting potentially best-in-class profil

VYGR.MX VYGR NBIX 0K6R.L

Read more →
Published at

Feb 26, 2025 12:00 AM

by gurufocus.com

positive

positive

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc. - VYGR

PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Voyager Therapeu

VYGR.MX VYGR

Read more →
Published at

Feb 25, 2025 1:00 PM

by gurufocus.com

mixed

mixed

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

LEXINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. ( VYGR), a biotechnology company dedicated to advancing neurogenetic medicines,

VYGR.MX VYGR NBIX 0K6R.L

Read more →
Published at

Feb 22, 2025 5:00 AM

by gurufocus.com

neutral

neutral

VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

PR NewswireLOS ANGELES, Feb. 21, 2025 LOS ANGELES, Feb. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announ

VYGR.MX VYGR

Read more →
Published at

Feb 19, 2025 12:00 AM

by gurufocus.com

positive

positive

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc. - VYGR

PR NewswireNEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Voyager Therape

VYGR.MX VYGR

Read more →
Published at

Feb 15, 2025 12:24 PM

by gurufocus.com

positive

positive

ARMISTICE CAPITAL, LLC's Strategic Acquisition of Voyager Therapeutics Shares

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio), a notable investment firm, executed a significant transaction by acquiring an additional 196,0

VYGR.MX VYGR PTCT

Read more →
Published at

Feb 11, 2025 1:15 PM

by manilatimes.net

mixed

mixed

Voyager Provides Update on SOD1 ALS Gene Therapy Program

**media[537489]**

VYGR.MX VYGR NBIX AZN 0K6R.L

Read more →
Published at

Feb 6, 2025 11:00 PM

by gurufocus.com

mixed

mixed

Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2024 Financial Results and Provides Financial Expectations for 2025

PR NewswireSAN DIEGO, Feb. 6, 2025 INGREZZA® (valbenazine) Fourth Quarter and Full Year 2024 Net Product Sales of $615 Million and $2.3 Billion, Represent

NBIX 0K6R.L FRGAP VYGR.MX VYGR

Read more →
Published at

Jan 30, 2025 11:06 PM

by seekingalpha.com

positive

positive

Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance (VYGR)

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's results. Click for this VYGR update.

VYGR.MX VYGR

Read more →
Published at

Jan 30, 2025 6:00 PM

by zacks.com

neutral

neutral

What Makes Voyager Therapeutics (VYGR) a New Buy Stock

Voyager Therapeutics (VYGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

VYGR

Read more →
Published at

Jan 16, 2025 1:27 AM

by gurufocus.com

positive

positive

Insider Sell: Robin Swartz Sells Shares of Voyager Therapeutics Inc

On January 14, 2025, Robin Swartz, Chief Operating Officer & Chief Business Officer at Voyager Therapeutics Inc, sold 3,087 shares of the company. Following thi

VYGR.MX VYGR

Read more →
Published at

Dec 29, 2024 12:22 PM

by insidermonkey.com

positive

positive

Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now?

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where Voyager Therapeutics, Inc. (NASDAQ:VYGR) stands against the other...

VYGR.MX VYGR

Read more →